The role of antibodies directed against the human leukocyte antigen (HLA) system has been well analyzed in rejection of solid organ transplantations [1, 2] and in transfusion medicine [3]. In the setting of allogeneic hematopoietic stem cells transplantation (HSCT), only in the recent years their importance has been better defined, even though antiHLA antibodies are frequently detectable in hematologic patients, due to sensitization from multiple transfusions, usually before the introduction of online universal leukoreduction, previous transplantations, and pregnancies in female patients.

Anti-HLA donor-specific antibodies in allogeneic stem cell transplantation: management and desensitization protocol / La Rocca, U.; Perrone, M. P.; Piciocchi, A.; Cinti, P.; Barberi, W.; Gozzer, M.; Baftii, M. S.; Torelli, G. F.; Quattrocchi, L.; Gesuiti, P.; Lattanzi, R.; Cavallari, C.; Ricci, R.; Laurenti, L.; Foa, R.; Girelli, G.; Iori, A. P.. - In: BONE MARROW TRANSPLANTATION. - ISSN 0268-3369. - (2019). [10.1038/s41409-019-0497-1]

Anti-HLA donor-specific antibodies in allogeneic stem cell transplantation: management and desensitization protocol

La Rocca U.;Piciocchi A.;Cinti P.;Barberi W.;Torelli G. F.;Quattrocchi L.;Lattanzi R.;Cavallari C.;Ricci R.;Foa R.;Girelli G.;Iori A. P.
2019

Abstract

The role of antibodies directed against the human leukocyte antigen (HLA) system has been well analyzed in rejection of solid organ transplantations [1, 2] and in transfusion medicine [3]. In the setting of allogeneic hematopoietic stem cells transplantation (HSCT), only in the recent years their importance has been better defined, even though antiHLA antibodies are frequently detectable in hematologic patients, due to sensitization from multiple transfusions, usually before the introduction of online universal leukoreduction, previous transplantations, and pregnancies in female patients.
Human leukocyte antigen (HLA); allogenic hematopoietic stem cells transplantation (HSCT)
01 Pubblicazione su rivista::01a Articolo in rivista
Anti-HLA donor-specific antibodies in allogeneic stem cell transplantation: management and desensitization protocol / La Rocca, U.; Perrone, M. P.; Piciocchi, A.; Cinti, P.; Barberi, W.; Gozzer, M.; Baftii, M. S.; Torelli, G. F.; Quattrocchi, L.; Gesuiti, P.; Lattanzi, R.; Cavallari, C.; Ricci, R.; Laurenti, L.; Foa, R.; Girelli, G.; Iori, A. P.. - In: BONE MARROW TRANSPLANTATION. - ISSN 0268-3369. - (2019). [10.1038/s41409-019-0497-1]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1285833
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 8
  • ???jsp.display-item.citation.isi??? 8
social impact